o-(2-fluoroethyl)tyrosine and Sarcoidosis

o-(2-fluoroethyl)tyrosine has been researched along with Sarcoidosis* in 2 studies

Other Studies

2 other study(ies) available for o-(2-fluoroethyl)tyrosine and Sarcoidosis

ArticleYear
Neurosarcoidosis on FET and FDG PET/CT.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:3

    O-(2-fluoroethyl)-L-tyrosine (FET) PET/CT is a promising imaging modality for brain tumor imaging because of its reported high sensitivity for biologically active tumor tissue. We present a case of biopsy-proven neurosarcoidosis showing FET uptake. It is an important cause of false-positive uptake on FET PET/CT.

    Topics: Adult; Brain Neoplasms; Central Nervous System Diseases; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Tyrosine

2017
Sarcoidois and radiation-induced astrogliosis causes pitfalls in neuro-oncologic positron emission tomography imaging by O-(2-[18F]fluoroethyl)-L-tyrosine.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Dec-20, Volume: 28, Issue:36

    Topics: Adult; Aged; Astrocytes; Brain Diseases; Humans; Male; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Sarcoidosis; Tyrosine

2010